Yanzhong Peng Selected Research

Dahuang Zhechong pill

1/2020	Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway.
4/2018	Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanzhong Peng Research Topics

Disease

3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 07/2018
2	Chronic Hepatitis B 10/2022 - 06/2016
2	Fibrosis (Cirrhosis) 01/2020 - 04/2018
2	Infections 01/2018 - 06/2016
1	Necrosis 07/2018
1	Neoplasms (Cancer) 07/2018
1	Chronic Hepatitis C 01/2018

Drug/Important Bio-Agent (IBA)

2	Dahuang Zhechong pillIBA 01/2020 - 04/2018
1	pradefovirIBA 10/2022
1	Hepatitis B e AntigensIBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	Alanine Transaminase (SGPT)IBA 07/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2018
1	RNA (Ribonucleic Acid)IBA 07/2018
1	Long Noncoding RNAIBA 04/2018
1	SofosbuvirIBA 01/2018
1	Hepatitis B Core AntigensIBA 06/2016
1	AntigensIBA 06/2016

Therapy/Procedure

1	Therapeutics 01/2018
1	Lasers (Laser) 06/2016